Management of Platinum-Resistant, Relapsed Epithelial Ovarian Cancer and New Drug Perspectives-Reference-Cited by-同舟云学术

Management of Platinum-Resistant, Relapsed Epithelial Ovarian Cancer and New Drug Perspectives

Published:2019-09-20 Issue:27 Volume:37 Page:2437-2448
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Pujade-Lauraine Eric¹,Banerjee Susana²,Pignata Sandro³

Affiliation:

1. ARCAGY-GINECO (Association de Recherche contre les Cancers dont Gynécologiques-Groupe des Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire, gynécologiques et du sein), Paris, France

2. The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom

3. Istituto Nazionale Tumori Fondazione G Pascale, Istituto di Ricovero e Cura a Carattere Scientifico, Napoli, Italy

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.19.00194

Reference93 articles.

1. Cancer of the Ovary

2. Recurrent ovarian cancer

3. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

4. Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds

5. Clinical Trials in Recurrent Ovarian Cancer

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer;Journal of Translational Medicine;2024-08-21

2. KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer;Molecular Carcinogenesis;2024-07-11

3. OPERA: a phase II trial of oregovomab plus non-platinum chemotherapy in PARP inhibitor/platinum-resistant ovarian cancer;Future Oncology;2024-06-28

4. Manganese primed immunochemotherapy in platinum-resistant/refractory ovarian cancer: a randomized, single-blind, placebo-controlled, phase 2 trial;2024-05-30

5. Exosomes in diagnostic and therapeutic applications of ovarian cancer;Journal of Ovarian Research;2024-05-25